Evidence map›Paper›PMID 34888282›Full record

ArticleFrontiers in public health2021

Application of SARS-CoV-2 Serology to Address Public Health Priorities.

Amy C Sherman, Teresa Smith, Yerun Zhu, Kaitlin Taibl, Jessica Howard-Anderson, Taylor Landay, Nora Pisanic, Jennifer Kleinhenz, Trevor W Simon, Daniel Espinoza and 15 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Amy C ShermanDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Teresa SmithRollins School of Public Health, Emory University, Atlanta, GA, United States.
Yerun ZhuDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Kaitlin TaiblRollins School of Public Health, Emory University, Atlanta, GA, United States.
Jessica Howard-AndersonDivision of Infectious Diseases, Emory University, Atlanta, GA, United States.
Taylor LandayRollins School of Public Health, Emory University, Atlanta, GA, United States.
Nora PisanicJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Jennifer KleinhenzDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Trevor W SimonDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Daniel EspinozaDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Neena EdupugantiDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Skyler HammondDepartment of Anthropology, Emory University, Atlanta, GA, United States.
Nadine RouphaelDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Huifeng ShenCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States.
Jessica K FairleyDivision of Infectious Diseases, Emory University, Atlanta, GA, United States.
Srilatha EdupugantiDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Jaime A Cardona-OspinaGrupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
Alfonso J Rodriguez-MoralesGrupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
Lakshmanane PremkumarDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
Jens WrammertEmory Vaccine Center, Yerkes National Primate Research Center, Atlanta, GA, United States.
Rick TarletonCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States.
Scott FridkinDivision of Infectious Diseases, Emory University, Atlanta, GA, United States.
Christopher D HeaneyJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Erin M SchererDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.
Matthew H CollinsDivision of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Training a New Generation of VaccinologistsT32AI074492 · NIAID · EMORY UNIVERSITY · PI Rama Rao Amara, Benjamin A Lopman · 2009 to 2026
$6.4M
Multiplex treatment outcomes test for Chagas diseaseR01AI125738 · NIAID · UNIVERSITY OF GEORGIA · PI TARLETON, RICK L · 2016 to 2020
$5.2M
Multiplex oral fluid antibody assay for arbovirus diagnosis, surveillance and preventionR21AI139784 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COLLINS, MATTHEW, HEANEY, CHRISTOPHER D · 2018 to 2019
$459k
NIAID NIH HHS R01 AI125738NIAID NIH HHS R21 AI139784NIAID NIH HHS T32 AI074492NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralHealth PrioritiesHumansSensitivity and SpecificityAntibodies, Viralantibody responseELISApublic healthSARS-CoV-2serology

Identifiers

PMID34888282
PMCPMC8650110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.